STERIS (STE) revenue: $5.9B
STERIS reported $5.9B of revenue for the year ended Mar 31, 2026, up 8.7% from $5.5B a year earlier.
From STERIS's filings with the SEC · Read the filing · STE stock page
STERIS revenue by year
#623 of 3,623 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Mar 31, 2026 | $5.9B | +9% |
| Mar 31, 2025 | $5.5B | +6% |
| Mar 31, 2024 | $5.1B | +13% |
| Mar 31, 2023 | $4.5B | +7% |
| Mar 31, 2022 | $4.2B | – |
Revenue of similar companies
Companies in the same industry as STERIS, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Intuitive Surgical | $10.1B | Dec 31, 2025 |
| Zimmer Biomet Holdings | $8.2B | Dec 31, 2025 |
| Edwards Lifesciences | $6.1B | Dec 31, 2025 |
| STERIS | $5.9B | Mar 31, 2026 |
| Align Technology | $4B | Dec 31, 2025 |
| Enovis | $2.2B | Dec 31, 2025 |
| MSA Safety | $1.9B | Dec 31, 2025 |
Questions and answers
What is STERIS's revenue?
STERIS reported $5.9B of revenue for the year ended Mar 31, 2026, up 8.7% from $5.5B a year earlier.
Numbers as reported in STERIS's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology